Samir R. Patel - 30 Jun 2024 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Role
Director
Signature
/s/ Wendy F. DiCicco, as Attorney-in-Fact for Samir Patel
Issuer symbol
AKTX
Transactions as of
30 Jun 2024
Net transactions value
$0
Form type
4
Filing time
02 Jul 2024, 16:30:08 UTC
Previous filing
04 Jun 2024
Next filing
02 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKTX Ordinary Shares, par value $0.0001 per share Award $0 +91,396,000 $0.000000 91,396,000 30 Jun 2024 Direct F1, F2
holding AKTX Ordinary Shares, par value $0.0001 per share 3,411,495,500 30 Jun 2024 PranaBio Investments LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
F2 These shares represent restricted stock units ("RSUs") granted under the Issuer's 2023 Equity Incentive Plan, with each such RSU representing the right to receive one ordinary share, par value $0.0001. One-hundered percent (100%) of the RSUs vested on the date of grant, or June 30, 2024.

Remarks:

See Exhibit 24.1 - Power of Attorney